
“Looking for the very highest quality products and the consistency of a high-tech pharmaceuticals operation? Vida expects to file its licensing application before the end of April, a schedule that should allow it to have the necessary license in hand by the third quarter of this year. In the meantime, the company is raising $1.5 million at $.25 per share. That represents a market value of only $6 million for a company that now owns a 315,000-square-foot production plant with a replacement value estimated at $30 million. Personally, I think this will turn out to be an extraordinary investment. In less than a year’s time, this $.25 financing round is going to look extremely cheap.”
Related posts:
Leave “My Cash” Alone, Says Oklahoma Sheriff
Trump plans to halt entrepreneur visas next week
As Chinese Stocks Sink, Bankers Begging Friends For Deposits On WeChat
Torture Memo Author John Yoo: President Can Wage War Without Declaration
Thirty-five Percent of Major U.S. Regulations Were Issued Without Public Notice
Pocket Enormous Tax Savings in Puerto Rico
September 5th: Jury Rights Day
China’s bear market won’t last – these two economies show why
Most Colorado Sheriffs Refuse to Enforce Gun Control Law
Glenn Greenwald: The real criminals in the Tarek Mehanna case
How Jeremy Hammond Exposed State's Plan to Criminalize Dissent
Drug Wars, Missing Money, and a Phantom $500 Million
Domain for Mintchip from the Royal Canadian Mint has expired
World’s First Bitcoin ATM Set to Go Live Tuesday
US blows out $16.7 trillion debt limit